Matthew James Vitalone1, Liang Wei, Masato Fujiki, Audrey H Lau, Erik Littau, Carlos Esquivel, Olivia M Martinez, Sheri M Krams. 1. 1 Division of Abdominal Transplantation, Department of Surgery, Stanford University School of Medicine, Stanford, CA. 2 School of Medicine, Sichuan Provincial People's Hospital, Chengdu, China. 3 Cleveland Clinic, Cleveland, OH. 4 Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA.
Abstract
BACKGROUND: Although the liver is less immunogenic than other solid organs, most liver transplant recipients receive lifelong immunosuppression. In both experimental models and clinical transplantation, total lymphoid irradiation (TLI) has been shown to induce allograft tolerance. Our goal was to identify the microRNAs (miRNAs) expressed in tolerant liver allograft recipients in an experimental model of TLI-induced tolerance. METHODS: To identify the miRNAs associated with TLI-induced tolerance, we examined syngeneic recipients (Lewis→Lewis) and allogeneic recipients (Dark Agouti→Lewis) of orthotropic liver transplants that received posttransplant TLI, allogeneic recipients that were not treated posttransplantation and experienced acute rejection, and native Dark Agouti livers. Quantitative-polymerase chain reaction miRNA array cards were used to profile liver grafts. RESULTS: We identified 12 miRNAs that were specifically and significantly increased during acute rejection. In early tolerance, 33 miRNAs were altered compared with syngeneic livers, with 80% of the miRNAs increased. In established tolerance, 42 miRNAs were altered. In addition, miR-142-5p and miR-181a demonstrated increased expression in tolerant livers (both early and established tolerance) as compared with syngeneic livers. A principal component analysis of all miRNAs assayed demonstrated a profile in established tolerance that was closely related to that seen in syngeneic livers. CONCLUSIONS: The miRNA profile of established tolerant allografts is very similar to syngeneic grafts, suggesting tolerance may be a return to an immunological state of quiescence.
BACKGROUND: Although the liver is less immunogenic than other solid organs, most liver transplant recipients receive lifelong immunosuppression. In both experimental models and clinical transplantation, total lymphoid irradiation (TLI) has been shown to induce allograft tolerance. Our goal was to identify the microRNAs (miRNAs) expressed in tolerant liver allograft recipients in an experimental model of TLI-induced tolerance. METHODS: To identify the miRNAs associated with TLI-induced tolerance, we examined syngeneic recipients (Lewis→Lewis) and allogeneic recipients (Dark Agouti→Lewis) of orthotropic liver transplants that received posttransplant TLI, allogeneic recipients that were not treated posttransplantation and experienced acute rejection, and native Dark Agouti livers. Quantitative-polymerase chain reaction miRNA array cards were used to profile liver grafts. RESULTS: We identified 12 miRNAs that were specifically and significantly increased during acute rejection. In early tolerance, 33 miRNAs were altered compared with syngeneic livers, with 80% of the miRNAs increased. In established tolerance, 42 miRNAs were altered. In addition, miR-142-5p and miR-181a demonstrated increased expression in tolerant livers (both early and established tolerance) as compared with syngeneic livers. A principal component analysis of all miRNAs assayed demonstrated a profile in established tolerance that was closely related to that seen in syngeneic livers. CONCLUSIONS: The miRNA profile of established tolerant allografts is very similar to syngeneic grafts, suggesting tolerance may be a return to an immunological state of quiescence.
Authors: Richard Danger; Annaïck Pallier; Magali Giral; Marc Martínez-Llordella; Juan José Lozano; Nicolas Degauque; Alberto Sanchez-Fueyo; Jean-Paul Soulillou; Sophie Brouard Journal: J Am Soc Nephrol Date: 2012-01-26 Impact factor: 10.121
Authors: Susan Kohlhaas; Oliver A Garden; Cheryl Scudamore; Martin Turner; Klaus Okkenhaug; Elena Vigorito Journal: J Immunol Date: 2009-03-01 Impact factor: 5.422
Authors: Nicholas J Kramer; Wei-Le Wang; Estefany Y Reyes; Bijender Kumar; Ching-Cheng Chen; Chandran Ramakrishna; Edouard M Cantin; Steven L Vonderfecht; Konstantin D Taganov; Nelson Chau; Mark P Boldin Journal: Blood Date: 2015-04-30 Impact factor: 22.113
Authors: M J Scian; D G Maluf; K G David; K J Archer; J L Suh; A R Wolen; M U Mba; H D Massey; A L King; T Gehr; A Cotterell; M Posner; V Mas Journal: Am J Transplant Date: 2011-07-27 Impact factor: 8.086
Authors: Fabien Stenard; Christine Nguyen; Ken Cox; Neeraja Kambham; Dale T Umetsu; Sheri M Krams; Carlos O Esquivel; Olivia M Martinez Journal: Pediatr Transplant Date: 2008-03-10
Authors: Alberto Baroja-Mazo; Beatriz Revilla-Nuin; Pascual Parrilla; Laura Martínez-Alarcón; Pablo Ramírez; José Antonio Pons Journal: World J Gastroenterol Date: 2016-09-14 Impact factor: 5.742